Patients with SR genomic lesions have significantly better survival outcomes than patients with AR genomic lesions. Kaplan-Meier curves assessed (A) OS and (B) RFS for the total genomic study cohort (57 patients). Statistical significance was determined by the log-rank survival (Mantel-Cox) test.